Showing results (31-40 of 11,495) with videos related to
Sort By:
Pageof 1,150
Biorxiv : the Preprint Server for Biology|January 16, 2026
Degradation of the TEAD•YAP/TAZ Transcription Factor Complex by Heterobifunctional Small Molecules that Bind to the TEAD Allosteric Lipid PocketI-Ju Yeh, Mona K Ghozayel, Khuchtumur Bum-Erdene, et al.ACS Chemical Biology|April 8, 2026
Degradation of the TEAD·YAP/TAZ Transcription Factor Complex by Heterobifunctional Small Molecules That Bind to the TEAD Allosteric Lipid PocketI-Ju Yeh, Mona K Ghozayel, Khuchtumur Bum-Erdene, et al.Journal of the American Chemical Society|August 19, 2004
Strategy in inhibition of cathepsin B, a target in tumor invasion and metastasisIn Taek Lim, Samy O Meroueh, Mijoon Lee, et al.Chemical Biology & Drug Design|May 17, 2008
PDBcal: a comprehensive dataset for receptor-ligand interactions with three-dimensional structures and binding thermodynamics from isothermal titration calorimetryLiwei Li, Justin J Dantzer, Jonathan Nowacki, et al.Journal of the American Chemical Society|June 15, 2006
Thermodynamics of interactions of vancomycin and synthetic surrogates of bacterial cell wallMikhail Rekharsky, Dusan Hesek, Mijoon Lee, et al.The Journal of Physical Chemistry. B|July 21, 2006
Computational investigation of irreversible inactivation of the zinc-dependent protease carboxypeptidase AJason B Cross, Thom Vreven, Samy O Meroueh, et al.Molecular Biosystems|July 9, 2009
Analysis of structured and intrinsically disordered regions of transmembrane proteinsBin Xue, Liwei Li, Samy O Meroueh, et al.Organic Letters|September 24, 2005
Synthesis of chiral 2-(4-phenoxyphenylsulfonylmethyl)thiiranes as selective gelatinase inhibitorsMijoon Lee, M Margarida Bernardo, Samy O Meroueh, et al.Molecular Biosystems|January 10, 2014
Exploring a structural protein-drug interactome for new therapeutics in lung cancerXiaodong Peng, Fang Wang, Liwei Li, et al.ACS Medicinal Chemistry Letters|September 9, 2010
Docking Small Molecules to Predicted Off-Targets of the Cancer Drug Erlotinib Leads to Inhibitors of Lung Cancer Cell Proliferation with Suitable In vitro Pharmacokinetic PropertiesLiwei Li, Jing Li, May Khanna, et al.Pageof 1,150